Brensocatib
Drug profile
Also known as: AZD7986, brinsupri, INS1007
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Brensocatib is an onp drug catalogued in DrugCentral. It was first approved by the FDA in 2025. DrugCentral lists 3 molecular targets, including CTSC, Ctsc and Ctsc. Recorded indications include Non-cystic fibrosis bronchiectasis.
- Approval status: onp (first approved 2025 by the FDA).
- Molecular targets: CTSC, Ctsc and Ctsc (3 listed in DrugCentral).
- Indications: Non-cystic fibrosis bronchiectasis.
- Molecular formula: C23H24N4O4; molecular weight 420.47 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Non-cystic fibrosis bronchiectasis
Mechanism & targets
Molecular targets (3)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Dipeptidyl peptidase 1 | CTSC | inhibitor | IC50 8.40 |
| Dipeptidyl peptidase 1 | Ctsc | inhibitor | IC50 7.70 |
| Dipeptidyl peptidase 1 | Ctsc | inhibitor | IC50 7.60 |
Regulatory approvals (2)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 2025-11-18 | EMA | — | Insmed Netherlands B.V. | |
| 2025-08-12 | FDA | — | Insmed Inc. |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Brensocatib is on its molecule page.
| Molecular formula | C23H24N4O4 |
|---|---|
| Molecular weight | 420.47 g/mol |
| CAS number | — |
| InChIKey | AEXFXNFMSAAELR-RXVVDRJESA-N |
| PubChem CID | 118253852 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Brensocatib used for?
DrugCentral lists the following indications for Brensocatib: Non-cystic fibrosis bronchiectasis.
How does Brensocatib work?
Its molecular targets in DrugCentral include CTSC (inhibitor), Ctsc (inhibitor) and Ctsc (inhibitor).
When was Brensocatib first approved?
Brensocatib was first approved by the FDA in 2025.
What is the chemical formula of Brensocatib?
Brensocatib has the molecular formula C23H24N4O4 and a molecular weight of 420.47 g/mol.
Browse: all drugs starting with B · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 5791 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL3900409 — compound record and bioactivity
- PubChem CID 118253852 — chemical identifiers
- DrugBank DB15638 — drug record
- FDA UNII 25CG88L0BB — substance identity
- DailyMed: FDA labels for Brensocatib — current prescribing information (label search)
- UniProt P53634 (CTSC) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.